Css LLC Catalyst Biosciences, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$0.91 - $4.16 $78,078 - $356,928	-85,800 Reduced 81.48%	19,500 $18,000
Q3 2021 Nov 15, 2021	SELL	$3.78 - $5.18 $520,128 - $712,768	-137,600 Reduced 56.65%	105,300 $433,000
Q2 2021 Aug 16, 2021	BUY	$4.1 - $5.33 $703,149 - $914,095	171,500 Added 240.2%	242,900 $1.05 Million
Q1 2021 May 17, 2021	BUY	$4.93 - $7.15 $352,002 - $510,510	71,400 New	71,400 $360,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.